Nose Neoplasms - 25 Studies Found
Terminated |
: Talactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck Cancer :
|
Active, not recruiting |
: Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer. :
|
Completed |
: TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and Neck :
|
Withdrawn |
: Everolimus, Erlotinib Hydrochloride, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer Previously Treated With Radiation Therapy :
|
Active, not recruiting |
: Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell Cancer :
|